The preclinical start-up is focused on developing novel drugs to stop and reverse the pathological accumulation of crosslinked proteins commonly observed in all major organs with age.
The preclinical start-up is focused on developing novel drugs to stop and reverse the pathological accumulation of crosslinked proteins commonly observed in all major organs with age.
.svg)
.svg)
.svg)
.svg)
.svg)